Clinical Trials on Haemopathy

Total 90 results

University Hospital, Lille

Recruiting

Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology.

Malignant Haemopathy

France
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Sequential Analysis in Patients With an Hemopathy (S-HEMO)

Hemopathy

France
Astellas Pharma S.A.S.

Completed

Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology (OLYMPE)

Antifungal Prophylaxis | Haemopathy

France
Institut Paoli-Calmettes
INSERM-U1068

Recruiting

Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation (SIA-CSH)

Malignant Hemopathy

France
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire; Université Jean Monnet de Saint-Etienne

Recruiting

Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells (MENTALO)

Malignant Hemopathy

France
RxCelerate Ltd
RxCelerate Limited

Unknown

Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)

Monoclonal Gammopathy of Unknown Significance

United Kingdom
Emory University
The Leukemia and Lymphoma Society

Recruiting

Rifaximin in Patients With Monoclonal Gammopathy

Waldenstrom Macroglobulinemia | Light Chain Deposition Disease | IgA Monoclonal Gammopathy | IgG Monoclonal Gammopathy | IgM Monoclonal Gammopathy | Monoclonal Gammopathy | Smoldering Waldenstrom Macroglobulinemia | Gammopathy, Monoclonal | Gammopathy Igg

United States
Centre Hospitalier Universitaire, Amiens

Unknown

Prevalence of Replication of Human Herpes Virus 6 (HHV6) in Blood and Skin During Exanthemia, in Patients With Hemopathy. Is There a Correlation With the Etiology of the Exanthema? (REPLIPO)

Exanthema | Hemopathy | HHV6

France
Rennes University Hospital

Completed

Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy (PACMoG)

Myeloma | Monoclonal Gammopathy | Monoclonal Gammopathy of Undetermined Signification

France
Association for Training, Education, and Research...

Active, not recruiting

Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders (LY-SET-HAPLO)

Refractory or Relapsed Lymphoid Haemopathy

France
University of Milano Bicocca

Completed

MGRS: Clinical-histological Features of a Multicenter Case Series

Monoclonal Gammopathy of Renal Significance

Italy
Dartmouth-Hitchcock Medical Center
Celgene Corporation

Terminated

Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance (MGUS)

Neuropathy | Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)

United States
Imagine Institute

Terminated

Evaluation of a Kit for the Prediction of the Risk of Graft Versus Host Disease (Predictor007)

Hemopathy

France
University Hospital, Toulouse
Janssen, LP; Ligue contre le cancer, France

Not yet recruiting

Real-life Management of Patients Eligible for CAR-T Cell Therapy (CARAVAGE)

Hemopathy

France
Academia Nacional de Medicina

Unknown

Diagnosis of MGRS in Patients With Paraproteinemias: Clinical, Anatomopathological and Pathophysiological Study (MGRS-CAPS)

Monoclonal Gammopathy of Renal Significance

Argentina
Centre Hospitalier Universitaire de Saint Etienne
Institut de Cancérologie de la Loire; Institut de Recherche Biomedicale des...

Terminated

Validation of Radio-induced Damage Biomarkers (BIOM-DRI)

Bone Metastasis | Malignant Hemopathy

France
UMC Utrecht
BeiGene

Not yet recruiting

Zanubrutinib Treatment in Patients With IgM Monoclonal Gammopathy and Antri-MAG Related Polyneuropathy (MAGNAZ)

Monoclonal Gammopathy of Uncertain Significance

Netherlands
Columbia University
Genzyme, a Sanofi Company

Recruiting

Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance

Monoclonal Gammopathy

United States
Oxford University Hospitals NHS Trust

Recruiting

A Prospective Long-term Observational Study in Patients With Monoclonal Gammopathy of Undetermined Significance (SECURE)

MGUS

United Kingdom
Regeneron Pharmaceuticals

Not yet recruiting

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma (LINKER-MGUS1)

Monoclonal Gammopathy of Undetermined Significance (MGUS) | Smoldering Multiple Myeloma (SMM)
Peking University First Hospital

Recruiting

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

Multiple Myeloma | Amyloidosis | Smoldering Multiple Myeloma | Plasma Cell Leukemia | Cryoglobulinemia | Light Chain Deposition Disease | Castleman's Disease | Heavy Chain Deposition Disease | Polyneuropathy Organomegaly Endocrinopathy Monoclonal Gammopathy and Skin Changes | Monoclonal Gammopathy of Undetermined... and other conditions

China
Assistance Publique - Hôpitaux de Paris

Terminated

Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia

Malignant Hemopathy | Duration of Neutropenia Following Chemotherapy > 10 Days

France
Memorial Sloan Kettering Cancer Center
Janssen Pharmaceuticals

Recruiting

A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

Multiple Myeloma | Monoclonal Gammopathy of Renal Significance

United States
University of Miami

Withdrawn

Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat

Obesity | Overweight | Monoclonal Gammopathies
Assistance Publique - Hôpitaux de Paris
Hospices Civils de Lyon; University Hospital, Basel, Switzerland; University... and other collaborators

Completed

RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy

Polyneuropathy

France
Indiana University

Active, not recruiting

Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery

Monoclonal Gammopathy of Undetermined Significance

United States
University Hospital, Brest

Completed

Frequency and Characteristics of Pruritus in Patients With Monoclonal Gammopathy (PRURIGAMMA)

Pruritus | Monoclonal Gammopathy

France
Georgetown University
Janssen, LP

Recruiting

Daratumumab for Polyneuropathy Associated With MGUS (Dara-MGUS)

Monoclonal Gammopathy of Undetermined Significance | Peripheral Neuropathy

United States
Oxford University Hospitals NHS Trust
Amgen

Completed

The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss (LOOMIS)

Myeloma | Smouldering Myeloma | Monoclonal Gammopathy of Undetermined Significance (MGUS)

United Kingdom
Shanghai Zhongshan Hospital

Recruiting

The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study (CHAPERONE)

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance

China
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

Monoclonal Gammopathy of Undetermined Significance | Plasma Cell Myeloma

United States
Mayo Clinic
Genentech, Inc.; Biogen; National Center for Research Resources (NCRR)

Terminated

Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance

Precancerous Condition

United States
National Taiwan University Hospital

Unknown

Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis

Tuberculosis | Monoclonal Gammopathy

Taiwan
National Cancer Institute (NCI)

Withdrawn

Imaging Studies and the Development of Multiple Myeloma

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma
National Cancer Institute (NCI)

Completed

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States
University of Iceland
Memorial Sloan Kettering Cancer Center; Landspitali University Hospital; deCODE... and other collaborators

Active, not recruiting

Iceland Screens, Treats or Prevents Multiple Myeloma (iStopMM)

Monoclonal Gammopathy of Undetermined Significance

Iceland
Dana-Farber Cancer Institute
The Leukemia and Lymphoma Society

Recruiting

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Myelodysplastic-Myeloproliferative Diseases | Waldenstrom Macroglobulinemia | Smoldering Multiple Myeloma | Chronic Lymphocytic Leukemia (CLL) | Hematological Malignancies | Monoclonal Gammopathy of Undetermined Significance (MGUS) | B-cell Malignancy, Low-grade | Myelodysplastic Syndrome With Low-grade... and other conditions

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma

Multiple Myeloma | Plasma Cell Myeloma | Precancerous Condition

United States
Zhujiang Hospital
National Natural Science Foundation of China

Recruiting

Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis

Multiple Myeloma | Monoclonal Gammopathies | M-protein

China
Assistance Publique - Hôpitaux de Paris
INSERM UMR 1163

Not yet recruiting

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies (GEN-HEMO-INF)

Multiple Myeloma | Waldenstrom Macroglobulinemia | Monoclonal Gammopathy of Undetermined Significance

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Isatuximab in Type I Cryoglobulinemia (ICE)

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Cryoglobulinemic Vasculitis
Radboud University Medical Center
Novartis

Completed

Efficacy and Safety of Canakinumab in Schnitzler Syndrome

Schnitzler Syndrome

Netherlands
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Recruiting

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States
Case Comprehensive Cancer Center

Withdrawn

Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma

Myeloma | Smoldering Myeloma | Monoclonal Gammopathy

United States
National Cancer Institute (NCI)

Terminated

Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

Monoclonal Gammopathy of Undetermined Significance | Smoldering Myeloma

United States
Dana-Farber Cancer Institute

Completed

Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma

Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States
Yale University

Completed

Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients (SHIVERING)

Influenza | Gammopathy

United States
Case Comprehensive Cancer Center

Recruiting

Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States
Memorial Sloan Kettering Cancer Center
Paula and Rodger Riney Foundation; Plantable; M and M labs; VeggieDoctor; Sabinsa...

Recruiting

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance

United States
University of Miami

Recruiting

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions (TRANSFORMM)

Multiple Myeloma | Monoclonal Gammopathy of Undetermined Significance | Smoldering Multiple Myeloma

United States

Clinical Trials on Haemopathy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations